Efficacy News and Research

RSS
AstraZeneca's COVID-19 vaccine protects against symptomatic disease

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

SARS-CoV-2 variants develop resistance against type I interferons

SARS-CoV-2 variants develop resistance against type I interferons

Vaccine passports raise questions of equity, security, and privacy

Vaccine passports raise questions of equity, security, and privacy

Clofazimine inhibits coronaviruses including SARS-CoV-2, study finds

Clofazimine inhibits coronaviruses including SARS-CoV-2, study finds

People's politics, values shape COVID-19 risk perception and adoption of protective behaviors

People's politics, values shape COVID-19 risk perception and adoption of protective behaviors

ChAdOx1 nCoV-19 offers less protection against South African SARS-CoV-2 variant

ChAdOx1 nCoV-19 offers less protection against South African SARS-CoV-2 variant

$11 million COBRE funding will help create Center for Pre-Clinical Cancer Research at LSU SVM

$11 million COBRE funding will help create Center for Pre-Clinical Cancer Research at LSU SVM

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Children at high risk of dyslexia face difficulty in learning nonsensical words

Children at high risk of dyslexia face difficulty in learning nonsensical words

New variant may not have changed COVID-19 pandemic course in UK, says study

New variant may not have changed COVID-19 pandemic course in UK, says study

Study examines efficacy of Pfizer-BioNTech mRNA COVID-19 vaccine across demographic groups

Study examines efficacy of Pfizer-BioNTech mRNA COVID-19 vaccine across demographic groups

Study shows how ACE2 mutations influence SARS-CoV-2 spike binding in humans and animals

Study shows how ACE2 mutations influence SARS-CoV-2 spike binding in humans and animals

SARS-CoV-2 vaccination should be carefully targeted towards certain groups, say researchers

SARS-CoV-2 vaccination should be carefully targeted towards certain groups, say researchers

New study provides comparative analysis of twelve COVID-19 vaccines

New study provides comparative analysis of twelve COVID-19 vaccines

Study highlights the importance of protecting elderly people from COVID-19 reinfection

Study highlights the importance of protecting elderly people from COVID-19 reinfection

New evidence supports ivermectin use in children weighing less than fifteen kilograms

New evidence supports ivermectin use in children weighing less than fifteen kilograms

New high-throughput system for testing drug candidates to treat brain diseases

New high-throughput system for testing drug candidates to treat brain diseases

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

Using nanoparticles for efficient delivery of antimicrobial peptides to treat deep infections

Using nanoparticles for efficient delivery of antimicrobial peptides to treat deep infections

Novel cancer-fighting gene therapy enters phase I clinical trial

Novel cancer-fighting gene therapy enters phase I clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.